Treatment of hemophiliacs with inhibitors: cost and effect on blood resources.
D003365:Costs and Cost Analysis; D005164:Factor IX / Q000627:therapeutic use*; D005169:Factor VIII / Q000627:therapeutic use*; D006467:Hemophilia A / Q000191:economics / Q000628:therapy*; D002836:Hemophilia B / Q000191:economics / Q000628:therapy*; D006760:Hospitalization; D006801:Humans; D009519:New York City
D005169:Factor VIII; D005164:Factor IX